In the last trading session, 74389.0 shares of the TELA Bio Inc (NASDAQ:TELA) were traded, and its beta was 0.76. Most recently the company’s share price was $1.44, and it changed around -$0.01 or -0.69% from the last close, which brings the market valuation of the company to $56.96M. TELA currently trades at a discount to its 52-week high of $6.06, offering almost -320.83% off that amount. The share price’s 52-week low was $0.86, which indicates that the current value has risen by an impressive 40.28% since then.
TELA Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended TELA as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. TELA Bio Inc is expected to report earnings per share of -0.19 for the current quarter.
TELA Bio Inc (NASDAQ:TELA) trade information
Instantly TELA has showed a red trend with a performance of -0.69% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.4985 on recent trading dayincreased the stock’s daily price by 3.9%. The company’s shares are currently down -52.32% year-to-date, but still up 30.91% over the last five days. On the other hand, TELA Bio Inc (NASDAQ:TELA) is 48.15% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $11, which translates to bulls needing to increase their stock price by 86.91% from its current value. Analyst projections state that TELA is forecast to be at a low of $8 and a high of $20.
TELA Bio Inc (TELA) estimates and forecasts
The year-over-year growth rate is expected to be 24.18%, up from the previous year.
Consensus estimates provided by 5 financial analysts predict the company will bring in an average of 20.67M in revenue for the current quarter. 5 analysts expect TELA Bio Inc to make 22.22M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 16.09M and 18.96M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 28.46%. Forecasts for the next quarter put sales growth at 17.23%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 12.91%.
TELA Dividends
TELA Bio Inc’s next quarterly earnings report is expected to be released in June.
ORBIMED ADVISORS LLC, with 9.9644% or 2.46 million shares worth $11.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.1 shares worth $1.59 million, making up 2.79% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 738.48 shares worth around $1.06 million, which represents about 1.87% of the total shares outstanding.
